Navigation Links
Covance to Present at Citi 2012 Global Health Care Conference
Date:2/24/2012

PRINCETON, N.J., Feb. 24, 2012 /PRNewswire/ -- Covance Inc. (NYSE: CVD) today announced that it will present at the Citi 2012 Global Health Care Conference on Tuesday, February  28, 2012 at 9:00 a.m. (ET). Investors may access a live webcast of the presentation at www.covance.com. In order to register and download any necessary software, please log on 10 minutes early.

Covance, with headquarters in Princeton, New Jersey, is one of the world's largest and most comprehensive drug development services companies with annual revenues greater than $2 billion, global operations in more than 30 countries, and more than 11,000 employees worldwide. Information on Covance's products and services, recent press releases, and SEC filings can be obtained through its website at www.covance.com.

Statements contained in this press release (and in the webcast announced in this press release), which are not historical facts, such as statements about prospective earnings, savings, revenue, operations, revenue, earnings growth, and other financial results are forward-looking statements pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All such forward-looking statements including the statements contained herein regarding anticipated trends in the Company's business are based largely on management's expectations and are subject to and qualified by risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. These risks and uncertainties include, without limitation, competitive factors, outsourcing trends in the pharmaceutical industry, levels of industry research and development spending, the Company's ability to continue to attract and retain qualified personnel, the fixed price nature of contracts or the loss or delay of large studies, risks associated with acquisitions and investments, the Company's ability to increase order volume, the pace of translation of orders into revenue in late-stage development services, testing mix and geographic mix of kit receipts in central laboratories, fluctuations in currency exchange rates, and other factors described in the Company's filings with the Securities and Exchange Commission including its Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. The Company undertakes no duty to update any forward looking statement to conform the statement to actual results or changes in the Company's expectations.


'/>"/>
SOURCE Covance Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Covance Board Authorizes $300 Million Stock Buyback
2. Covance Inc. Invites You to Join the Webcast of Its Fourth Quarter 2011 Financial Results Conference Call
3. Covance to Present at Credit Suisse 2011 Healthcare Conference
4. Covance Central Laboratory Services Ranks #1 in Global Investigator Satisfaction Survey
5. Covance Receives Good Laboratory Practice Certification for Its Early Development Facility in Shanghai, China
6. Covance Inc. Invites You to Join the Webcast of Its Third Quarter 2011 Financial Results Conference Call
7. Covance to Present at Morgan Stanley Global Healthcare Conference
8. Covance Reports Second Quarter Revenue of $518 Million, GAAP EPS of $0.61, and Pro Forma EPS of $0.66
9. Covance to Present at Bairds 2011 Growth Stock Conference
10. Covance Inc. Invites You to Join the Webcast of Its First Quarter 2011 Financial Results Conference Call
11. Covance to Present at the 2nd Annual Morningstar/NYSSA Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... 2016 Pharmaceutical giant Johnson & ... a woman who says its talc-based powder products caused ... Ristesund $5 million in compensatory damages and $50 ... http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , This is the ... In February, the same court awarded $72 million to ...
(Date:5/3/2016)... , May 3, 2016 ... Research Report provides a basic overview of the ... post which the surgical mesh report explores into ... Complete report on Surgical Mesh market ... and 98 tables and figures is available at ...
(Date:5/2/2016)... , May 2, 2016  While nearly three-quarters ... osteoporosis can have on their health, only about half ... according to the results of a new survey announced ... mark the start of National Osteoporosis Month, Hologic is ... which affects nearly 56 million Americans. Osteoporosis ...
Breaking Medicine Technology:
(Date:5/4/2016)... ... 2016 , ... Dr. Elyson and Dr. Assili, dentist in Northridge , ... tooth removal, a common dental procedure, is performed for many adolescents and young adults ... in risks of complications. By providing wisdom tooth removal surgery at their office, Dr. ...
(Date:5/4/2016)... ... 04, 2016 , ... Nordic Naturals announces another breakthrough innovation—Omega ... This synergistic combination of omega-3 fatty acids and potent antioxidants contains 1000 mg ... glutathione and 200 mg of N-Acetylcysteine (NAC). , Each nutrient plays a ...
(Date:5/4/2016)... ... ... Francesca Loparco, Co-Founder of Queen City Dream Cars, an exotic car rental ... at Christenbury Eye Center. The entrepreneur struggled with her computer, riding horses and ... as her in-office consultation and eye exam. Francesca’s eyesight was restored to 20/20 in ...
(Date:5/4/2016)... ... May 04, 2016 , ... Pharmacy Times , ... it was chosen as the Pharmaceutical News Provider of the Year in the ... the hard work and dedication of community members who strive to make the ...
(Date:5/4/2016)... ... May 04, 2016 , ... ... small and compact tactical (6.7 inch) dual-light flashlights in models NSP-9842XL and ... NSP-9842XL (average retail starting at $59.95) uses 2 included CR-123 batteries to produce ...
Breaking Medicine News(10 mins):